On 04 May, Adar Poonawalla, CEO of Serum Institute of India, announced coronavirus vaccine ‘Covovax’ is available for everyone above 12 years. Now, Covovax is available for children all over the world.

“A lot of you have asked if Covovax is available for adults. The answer is yes, it is available for everyone above 12,” Poonawalla wrote on Twitter.

On Tuesday, Poonawalla announced that children aged 12 to 17 years could get the Serum Institute of India’s (SII) Covid-19 vaccine Covovax. The SII CEO also hailed Prime Minister Narendra Modi for his “vision of providing the vaccine for children.”

The statement mentioned on Twitter, “Covovax (@Novavax), is now available for children in India. This is the only vaccine manufactured in India that is also sold in Europe and has an efficacy of > 90 per cent. This is in line with Shri @narendramodi Ji’s vision of providing yet another vaccine to protect our children.”

Covovax is the second Covid-19 vaccine that has been manufactured by the SII, after Covishield. In December last year, the DCGI approved Covovax for emergency use in adults and approved the vaccine for emergency use in those aged 12. Last week, the National Technical Advisory Group on Immunisation (NTAGI) approved the Covid-19 vaccine for emergency use in children between the ages of 12 to 17.

The price of Rs one dose of the Covovax will be Rs 900 plus GST and the hospital service charge of Rs 150.